{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-324202","form_type":"8-K","ticker":"KURA","cik":"0001422143","company_name":"Kura Oncology, Inc.","filed_at":"2026-07-29T21:06:38+00:00","discovered_at":"2026-07-29T21:08:00.266569+00:00","generated_at":"2026-07-29T21:08:14.553301+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Kura Oncology amends executive severance agreements for CEO, CCO, and COO","bullets":["CEO Wilson: 12 months base salary (non-CIC) or 24 months base + 200% bonus (CIC), full equity acceleration.","CCO Powl and COO Ford: 12 months base (non-CIC) or 18 months base + 150% bonus (CIC), full equity acceleration.","All executives get COBRA premium continuation (12 months non-CIC, 18-24 months CIC) and option exercise extension to 12 months.","Amendments effective July 24-27, 2026; other terms unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-324202","json":"https://secwatch.observer/filing/0001193125-26-324202.json","markdown":"https://secwatch.observer/filing/0001193125-26-324202.md","text":"https://secwatch.observer/filing/0001193125-26-324202.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526324202/0001193125-26-324202-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526324202/d53075d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T21:08:14.553301+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}